Longeveron (LGVN) Return on Sales (2020 - 2026)

Longeveron's (LGVN) quarterly Return on Sales came in at 0.14% in Q1 2026, up 3.0% year-on-year from 0.14% in Q1 2025, and up 18.66% quarter-over-quarter from 0.17% in Q4 2025.

Longeveron (LGVN) Return on Sales (2020 - 2026) Analysis & Trends

Longeveron's Return on Sales history runs 7 years deep, the most recent figure standing at 0.14% for Q1 2026.

  • On a quarterly basis, Return on Sales rose 3.0% year-over-year to 0.14% in Q1 2026; TTM through Mar 2026 was 0.23%, a 13.0% decrease from a year earlier, with the FY2025 full-year figure at 0.2%, down 6.0% from the prior year.
  • Return on Sales advanced to 0.14% in Q1 2026 per LGVN's latest filing, from 0.17% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.06% in Q3 2024 and bottomed at 1.53% in Q1 2023.
  • The 5-year median for Return on Sales is 0.17% (2025), against an average of 0.35%.
  • Across the five-year window, Return on Sales sank 258 bps in 2022 and surged 145 bps in 2024, its largest moves.
  • Year by year, Return on Sales stood at 0.43% in 2022, then sank by 101 bps to 0.87% in 2023, then jumped by 90 bps to 0.09% in 2024, then slumped by 97 bps to 0.17% in 2025, then climbed by 19 bps to 0.14% in 2026.
  • Per Business Quant, the three latest LGVN Return on Sales figures stand at 0.14% (Q1 2026), 0.17% (Q4 2025), and 0.64% (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 0.00%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 0.00%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 0.00%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 0.00%
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Longeveron 3.97 Mn -11.79 Mn 264,000.00 -0.14%

Historic Data

Download Data
DateValue
Mar 31, 2026 -0.14%
Dec 31, 2025 -0.17%
Sep 30, 2025 -0.64%
Jun 30, 2025 -0.22%
Mar 31, 2025 -0.17%
Dec 31, 2024 -0.09%
Sep 30, 2024 -0.06%
Jun 30, 2024 -0.08%
Mar 31, 2024 -0.08%
Dec 31, 2023 -0.87%
Sep 30, 2023 -0.36%
Jun 30, 2023 -0.27%
Mar 31, 2023 -1.53%
Dec 31, 2022 -0.43%
Sep 30, 2022 -0.54%
Jun 30, 2022 -0.11%
Mar 31, 2022 -0.13%
Dec 31, 2021 2.15%
Sep 30, 2021 -0.99%
Jun 30, 2021 -0.41%